Stelvio Sestini is the director of the complex nuclear medicine structure of the Santo Stefano hospital, part of the company's diagnostic imaging department directed by Dr. Sandro Santini. Doctor Sestini, former acting director of the structure, graduated from the University of Florence in 1993 and specialized in nuclear medicine in 1998. Again from the University of Florence, he obtained his doctorate in 2004. research in applied clinical pathophysiology, discussing a thesis on Parkinson's disease, as well as being awarded the title of “Who's Who in the World 2009” for the progress achieved in Parkinson's research. In 1998 he was a Guest Researcher at the Department of Clinical Neurosciences of the Karolinska Institute in Stockholm where he achieved important results in the study of techniques for quantifying the cerebral uptake of radioreceptor drugs. In 2015, at the Department of Nuclear Medicine of the University of Rostock in Germany, you acquired the skills necessary for the implementation of new bio-molecular imaging techniques dedicated to the diagnosis and radio-metabolic treatment of cancer patients, in particular with neoplasia prostatic and neuroendocrine.
Since 1999 Sestini has been the medical director at the Prato Hospital and in 2018 he took on the role of acting director of nuclear medicine. Sestini has a brilliant CV in which numerous participations in conferences as a teacher stand out and a first-name scientific production strictly pertinent to the discipline published in national and international journals. Precisely for the activity carried out in the field of nuclear medicine and for the scientific recognition received, the professional was appointed coordinator of the nuclear neurology study group of the Italian Association of Nuclear Medicine.